» Articles » PMID: 37335084

Amyloids and Brain Cancer: Molecular Linkages and Crossovers

Overview
Journal Biosci Rep
Specialty Cell Biology
Date 2023 Jun 19
PMID 37335084
Authors
Affiliations
Soon will be listed here.
Abstract

Amyloids are high-order proteinaceous formations deposited in both intra- and extracellular spaces. These aggregates have tendencies to deregulate cellular physiology in multiple ways; for example, altered metabolism, mitochondrial dysfunctions, immune modulation, etc. When amyloids are formed in brain tissues, the endpoint often is death of neurons. However, interesting but least understood is a close connection of amyloids with another set of conditions in which brain cells proliferate at an extraordinary rate and form tumor inside brain. Glioblastoma is one such condition. Increasing number of evidence indicate a possible link between amyloid formation and depositions in brain tumors. Several proteins associated with cell cycle regulation and apoptotic pathways themselves have shown to possess high tendencies to form amyloids. Tumor suppressor protein p53 is one prominent example that mutate, oligomerize and form amyloids leading to loss- or gain-of-functions and cause increased cell proliferation and malignancies. In this review article, we present available examples, genetic links and common pathways that indicate that possibly the two distantly placed pathways: amyloid formation and developing cancers in the brain have similarities and are mechanistically intertwined together.

Citing Articles

Insights into Dysregulated Neurological Biomarkers in Cancer.

Duranti E, Villa C Cancers (Basel). 2024; 16(15).

PMID: 39123408 PMC: 11312413. DOI: 10.3390/cancers16152680.


Distinguishing IDH mutation status in gliomas using FTIR-ATR spectra of peripheral blood plasma indicating clear traces of protein amyloid aggregation.

Kino S, Kanamori M, Shimoda Y, Niizuma K, Endo H, Matsuura Y BMC Cancer. 2024; 24(1):222.

PMID: 38365669 PMC: 10870484. DOI: 10.1186/s12885-024-11970-y.

References
1.
Mehringer J, Navarro J, Touraud D, Schneuwly S, Kunz W . Phosphorylated resveratrol as a protein aggregation suppressor and . RSC Chem Biol. 2022; 3(2):250-260. PMC: 8826510. DOI: 10.1039/d1cb00220a. View

2.
Wolf E, Fingleton B, Hasty A . The therapeutic potential of TREM2 in cancer. Front Oncol. 2022; 12:984193. PMC: 9479103. DOI: 10.3389/fonc.2022.984193. View

3.
Aldoghachi A, Aldoghachi A, Breyne K, Ling K, Cheah P . Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme. Neuroscience. 2022; 491:240-270. DOI: 10.1016/j.neuroscience.2022.03.030. View

4.
Galvao R, Kasina A, McNeill R, Harbin J, Foreman O, Verhaak R . Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process. Proc Natl Acad Sci U S A. 2014; 111(40):E4214-23. PMC: 4210043. DOI: 10.1073/pnas.1414389111. View

5.
Fields J, Spencer B, Swinton M, Qvale E, Marquine M, Alexeeva A . Alterations in brain TREM2 and Amyloid-β levels are associated with neurocognitive impairment in HIV-infected persons on antiretroviral therapy. J Neurochem. 2018; 147(6):784-802. PMC: 6310632. DOI: 10.1111/jnc.14582. View